University of the Sciences in Philadelphia
’s board of trustees has approved changing the name of its College of Health Sciences
to the Samson College of Health Sciences in honor of Marvin Samson (at right
), a longtime friend, honorary alumnus, and trustee of the University. The already established school is one of the five colleges comprising the University.
“Through the naming of the Samson College of Health Sciences, I cannot think of a better way to express the University's gratitude to Marvin for his support and dedication,” said University President Dr. Philip P. Gerbino. “We are planning a celebration of the name change in the fall.”
Samson is currently vice chairman of the University's board and has served on it in numerous capacities since 1991. Over the years, his gifts to the University have supported the Marvin Samson Center
for the History of Pharmacy Museum and the Misher Visiting Professorship in the Humanities. In addition, he chaired the University's most recent capital campaign.
“As I see it, the most important job of the present is to educate future leaders in and providers of healthcare. We, in the greater Philadelphia
area, are blessed with some of the most prestigious educational institutions in the world, and I am exceptionally proud to be associated with University of the Sciences. Having the College of Health Sciences
bear my name is an indescribable honor, and I look forward to seeing its graduates make significant contributions to the well-being of our community and beyond,” Samson said.
A world-renowned leader in injectable manufacturing and delivery systems, Samson is founder and chief executive officer of Samson Medical Technologies, LLC, a company specializing in injectable drug delivery systems and programs for hospital and alternate site pharmacists. A native of Philadelphia
, Samson received his BS in chemistry from Temple University
. In 1967, he helped to found Elkins-Sinn, Inc., where he was president and CEO for 18 years, and today it is one of the largest generic injectables companies in the U.S.
Following Elkins-Sinn, Samson founded and was president and CEO at Marsam Pharmaceuticals, Inc., from 1985 to 1998. After establishing Samson Medical Technologies in 1998, he joined SICOR Pharmaceuticals, Inc., as president and CEO before it was acquired by Teva Pharmaceutical Industries, Ltd., and he was elected group vice president of Worldwide Injectables. He recently joined Qualitest Pharmaceuticals as chairman of the board.
Samson holds five U.S.
patents pertaining to pharmaceutical manufacturing, serves on numerous boards, and provides charitable support of educational institutions, hospitals, healthcare research and development, and children's programs.
With its majors in occupational therapy and physical therapy, plus fitness and health management, health science, medical technology, and physician assistant studies, Samson College
will continue to provide its students with hands-on training in these vital healthcare fields.
At University of the Sciences in Philadelphia
, students embark on a challenging learning experience in a proving ground for successful professionals in the healthcare-related fields. A private, coeducational institution dedicated to education, research, and service, and distinguished as the nation’s first college of pharmacy, the University has produced leaders in the healthcare marketplace since its founding in 1821, including founders of six of the top pharmaceutical companies in the world. With undergraduate, graduate, and doctoral degree programs in such disciplines as pharmacy, bioinformatics, physical therapy, healthcare business, and health policy, the 3,000 students in the University of the Sciences’ five colleges learn to excel in scientific analysis and to apply their skills to improving healthcare in their communities and in the lives of people worldwide. For more information about University of the Sciences, visit www.usp.edu